amiodarone has been researched along with Periphlebitis in 13 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Periphlebitis: Periphlebitis is inflammation of the outer coat of a vein or of tissues surrounding the vein.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to evaluate the effect of topical chamomile on the incidence of phlebitis due to the administration of an amiodarone infusion into the peripheral vein." | 9.24 | Efficacy of topical chamomile on the incidence of phlebitis due to an amiodarone infusion in coronary care patients: a double-blind, randomized controlled trial. ( Asefzadeh, S; Nassiri-Asl, M; Sharifi-Ardani, M; Yekefallah, L, 2017) |
| "Intravenous amiodarone is considered an effective treatment option for cardiac ventricular and atrial arrhythmias." | 9.24 | Effects of injection-site splinting on the incidence of phlebitis in patients taking peripherally infused amiodarone: A randomized clinical trial. ( Ayat-Isfahani, F; Davoudi, B; Jalali, A; Pashang, M; Sadeghian, S, 2017) |
| "Intravenous amiodarone is the gold-standard treatment for arrhythmias, but phlebitis is a common adverse effect." | 9.01 | Phlebitis in Intravenous Amiodarone Administration: Incidence and Contributing Factors. ( Moore, Z; Oragano, CA; Patton, D, 2019) |
| "To evaluate efficacy and safety of intravenous amiodarone for conversion of recent-onset atrial fibrillation." | 8.81 | Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials. ( Hilleman, DE; Spinler, SA, 2002) |
| "This evidence-based quality improvement initiative aimed to decrease and enhance early detection of phlebitis in patients receiving amiodarone." | 7.96 | Reducing the Incidence of Amiodarone-related Phlebitis Through Utilization of Evidence-based Practice. ( Fischer-Cartlidge, E; Murphy, J; Murphy, K, 2020) |
| "Intravenous amiodarone is an important treatment for arrhythmias, but peripheral infusion is associated with direct irritation of vessel walls and phlebitis rates of 8% to 55%." | 7.79 | Phlebitis in amiodarone administration: incidence, contributing factors, and clinical implications. ( Becker, N; Cotter, T; Forsey, L; Haynes, A; Matsuda, K; Norton, L; Ottoboni, LK; Pummer, E; Varady, A; Wang, P; Yang-Lu, CY, 2013) |
| "Nurses noted that the rate of phlebitis was high when intravenous amiodarone was infused via a peripheral site." | 7.78 | Incidence and severity of phlebitis in patients receiving peripherally infused amiodarone. ( Boyce, BA; Yee, BH, 2012) |
| "Postoperative atrial fibrillation following cardiothoracic surgery is common and frequently managed with intravenous (IV) amiodarone." | 7.74 | The incidence of phlebitis with intravenous amiodarone at guideline dose recommendations. ( Boyd, SY; Duffy, B; Roth, JE; Rubal, BJ; Slim, AM, 2007) |
| "The aim of this study was to evaluate the effect of topical chamomile on the incidence of phlebitis due to the administration of an amiodarone infusion into the peripheral vein." | 5.24 | Efficacy of topical chamomile on the incidence of phlebitis due to an amiodarone infusion in coronary care patients: a double-blind, randomized controlled trial. ( Asefzadeh, S; Nassiri-Asl, M; Sharifi-Ardani, M; Yekefallah, L, 2017) |
| "Intravenous amiodarone is considered an effective treatment option for cardiac ventricular and atrial arrhythmias." | 5.24 | Effects of injection-site splinting on the incidence of phlebitis in patients taking peripherally infused amiodarone: A randomized clinical trial. ( Ayat-Isfahani, F; Davoudi, B; Jalali, A; Pashang, M; Sadeghian, S, 2017) |
| "Intravenous amiodarone is the gold-standard treatment for arrhythmias, but phlebitis is a common adverse effect." | 5.01 | Phlebitis in Intravenous Amiodarone Administration: Incidence and Contributing Factors. ( Moore, Z; Oragano, CA; Patton, D, 2019) |
| "To evaluate efficacy and safety of intravenous amiodarone for conversion of recent-onset atrial fibrillation." | 4.81 | Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials. ( Hilleman, DE; Spinler, SA, 2002) |
| "This evidence-based quality improvement initiative aimed to decrease and enhance early detection of phlebitis in patients receiving amiodarone." | 3.96 | Reducing the Incidence of Amiodarone-related Phlebitis Through Utilization of Evidence-based Practice. ( Fischer-Cartlidge, E; Murphy, J; Murphy, K, 2020) |
| "Intravenous amiodarone is an important treatment for arrhythmias, but peripheral infusion is associated with direct irritation of vessel walls and phlebitis rates of 8% to 55%." | 3.79 | Phlebitis in amiodarone administration: incidence, contributing factors, and clinical implications. ( Becker, N; Cotter, T; Forsey, L; Haynes, A; Matsuda, K; Norton, L; Ottoboni, LK; Pummer, E; Varady, A; Wang, P; Yang-Lu, CY, 2013) |
| "Nurses noted that the rate of phlebitis was high when intravenous amiodarone was infused via a peripheral site." | 3.78 | Incidence and severity of phlebitis in patients receiving peripherally infused amiodarone. ( Boyce, BA; Yee, BH, 2012) |
| "Postoperative atrial fibrillation following cardiothoracic surgery is common and frequently managed with intravenous (IV) amiodarone." | 3.74 | The incidence of phlebitis with intravenous amiodarone at guideline dose recommendations. ( Boyd, SY; Duffy, B; Roth, JE; Rubal, BJ; Slim, AM, 2007) |
| "Amiodarone (AM) is a drug commonly used in patients with ventricular arrhythmias." | 1.91 | Protective effect of isoliquiritigenin in amiodarone-induced damage of human umbilical vein endothelial cells. ( Chang, YQ; Guo, JL; Guo, XJ; Han, X; Wang, JJ; Yan, XY; Zhang, BL, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, JL | 1 |
| Han, X | 1 |
| Yan, XY | 1 |
| Wang, JJ | 1 |
| Chang, YQ | 1 |
| Zhang, BL | 1 |
| Guo, XJ | 1 |
| Murphy, K | 1 |
| Murphy, J | 1 |
| Fischer-Cartlidge, E | 1 |
| Sharifi-Ardani, M | 1 |
| Yekefallah, L | 1 |
| Asefzadeh, S | 1 |
| Nassiri-Asl, M | 1 |
| Oragano, CA | 1 |
| Patton, D | 1 |
| Moore, Z | 1 |
| Dixon, HA | 1 |
| Hort, AL | 1 |
| Wright, CM | 1 |
| Norton, L | 1 |
| Ottoboni, LK | 1 |
| Varady, A | 1 |
| Yang-Lu, CY | 1 |
| Becker, N | 1 |
| Cotter, T | 1 |
| Pummer, E | 1 |
| Haynes, A | 1 |
| Forsey, L | 1 |
| Matsuda, K | 1 |
| Wang, P | 1 |
| Hannibal, GB | 1 |
| Ayat-Isfahani, F | 1 |
| Pashang, M | 1 |
| Davoudi, B | 1 |
| Sadeghian, S | 1 |
| Jalali, A | 1 |
| Boyce, BA | 1 |
| Yee, BH | 1 |
| Slim, AM | 1 |
| Roth, JE | 1 |
| Duffy, B | 1 |
| Boyd, SY | 1 |
| Rubal, BJ | 1 |
| Hilleman, DE | 2 |
| Spinler, SA | 1 |
| Ward, GH | 1 |
| Nolan, PE | 1 |
| White, M | 1 |
| Yalkowsky, SH | 1 |
| Hansen, JM | 1 |
| Mohiuddin, SM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Using Time-dependent Intravenous Infusions of Amiodarone for Conversions to Sinus Rhythms in Patients With Paroxysmal Atrial Fibrillation[NCT03432663] | Phase 4 | 60 participants (Actual) | Interventional | 2008-08-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for amiodarone and Periphlebitis
| Article | Year |
|---|---|
Phlebitis in Intravenous Amiodarone Administration: Incidence and Contributing Factors.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Incidence; Infusions, Intravenous; Phlebitis; Severity o | 2019 |
Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cohort Studies; Humans; Hypote | 2002 |
2 trials available for amiodarone and Periphlebitis
| Article | Year |
|---|---|
Efficacy of topical chamomile on the incidence of phlebitis due to an amiodarone infusion in coronary care patients: a double-blind, randomized controlled trial.
Topics: Administration, Topical; Amiodarone; Chamomile; Double-Blind Method; Female; Humans; Incidence; Infu | 2017 |
Effects of injection-site splinting on the incidence of phlebitis in patients taking peripherally infused amiodarone: A randomized clinical trial.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Incidence; Infusions | 2017 |
9 other studies available for amiodarone and Periphlebitis
| Article | Year |
|---|---|
Protective effect of isoliquiritigenin in amiodarone-induced damage of human umbilical vein endothelial cells.
Topics: Amiodarone; Chalcones; Human Umbilical Vein Endothelial Cells; Humans; Phlebitis | 2023 |
Reducing the Incidence of Amiodarone-related Phlebitis Through Utilization of Evidence-based Practice.
Topics: Amiodarone; Evidence-Based Practice; Humans; Incidence; Infusions, Intravenous; Phlebitis; Quality I | 2020 |
Amiodarone-induced phlebitis remains an issue in spite of measures to reduce its occurrence.
Topics: Aged; Amiodarone; Child, Preschool; Female; Humans; Incidence; Infant; Infant, Newborn; Infusions, I | 2019 |
Phlebitis in amiodarone administration: incidence, contributing factors, and clinical implications.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; California; Cardiac Care Facilit | 2013 |
Peripheral Phlebitis Related to Amiodarone Infusion.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Critical Care Nursing; Humans; Phlebitis; P | 2016 |
Incidence and severity of phlebitis in patients receiving peripherally infused amiodarone.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheterization, P | 2012 |
The incidence of phlebitis with intravenous amiodarone at guideline dose recommendations.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Incidence; Infusions, | 2007 |
Studies in phlebitis. II. Early detection of amiodarone-induced phlebitis in a rabbit model.
Topics: Amiodarone; Animals; Body Temperature; Ear, External; Phlebitis; Rabbits | 1991 |
Amiodarone-induced infusion phlebitis.
Topics: Aged; Aged, 80 and over; Amiodarone; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Phle | 1987 |